{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:16:56Z","timestamp":1783487816611,"version":"3.55.0"},"reference-count":34,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2,1]]},"DOI":"10.1210\/jc.2012-2901","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T22:42:57Z","timestamp":1357684977000},"page":"761-768","source":"Crossref","is-referenced-by-count":7,"title":["IGF-I Bioactivity Might Reflect Different Aspects of Quality of Life Than Total IGF-I in GH-Deficient Patients During GH Treatment"],"prefix":"10.1210","volume":"98","author":[{"given":"Aimee J.","family":"Varewijck","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W. J.","family":"Lamberts","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian J. C. M. M.","family":"Neggers","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo J.","family":"Hofland","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A. M. J. L.","family":"Janssen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041115533372100_B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/ghir.2001.0263","article-title":"Growth hormone replacement therapy for adults: into the new millennium","volume":"12","author":"Simpson","year":"2002","journal-title":"Growth Horm IGF Res"},{"key":"2019041115533372100_B2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1651-2227.1989.tb11249.x","article-title":"Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency","volume":"356","author":"McGauley","year":"1989","journal-title":"Acta Paediatr Scand Suppl"},{"key":"2019041115533372100_B3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2265.1998.00634.x","article-title":"One-year follow-up of quality of life in adults with untreated growth hormone deficiency","volume":"49","author":"Badia","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115533372100_B4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2265.2000.00899.x","article-title":"Application of a disease-specific, quality-of-life measure (QOL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by rasch analysis","volume":"52","author":"Wiren","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115533372100_B5","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/jc.2003-030134","article-title":"Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H)","volume":"89","author":"Rosilio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115533372100_B6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2265.2001.01275.x","article-title":"Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement","volume":"54","author":"Ahmad","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115533372100_B7","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1210\/jc.2002-021792","article-title":"Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module","volume":"88","author":"Blum","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115533372100_B8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/eje.0.1450255","article-title":"Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency","volume":"145","author":"Herschbach","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2019041115533372100_B9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2265.1999.00722.x","article-title":"Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults","volume":"50","author":"Murray","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115533372100_B10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2265.1999.00838.x","article-title":"Influences on quality of life in GH deficient adults and their effect on response to treatment","volume":"51","author":"Murray","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115533372100_B11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/edrv.22.1.0419","article-title":"The somatomedin hypothesis: 2001","volume":"22","author":"Le Roith","year":"2001","journal-title":"Endocr Rev"},{"key":"2019041115533372100_B12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","article-title":"Consensus guidelines for the diagnosis and treatment of adults with GH deficiency. II: A statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2019041115533372100_B13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1530\/eje.0.1340352","article-title":"New approach to the diagnosis of growth hormone deficiency in adults","volume":"134","author":"Ghigo","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"2019041115533372100_B14","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2011-0051","article-title":"IGF-I bioactivity better reflects growth hormone deficiency than total IGF-I","volume":"96","author":"Varewijck","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115533372100_B15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11102-007-0032-z","article-title":"IGF-I assays: current assay methodologies and their limitations","volume":"10","author":"Clemmons","year":"2007","journal-title":"Pituitary"},{"key":"2019041115533372100_B16","first-page":"E1149","article-title":"A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum","volume":"284","author":"Chen","year":"2003","journal-title":"Am J Physiol"},{"key":"2019041115533372100_B17","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1210\/jc.2007-2454","article-title":"Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays","volume":"93","author":"Brugts","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115533372100_B18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000329191","article-title":"IGF-I: Pro's and con's of a bioassay","volume":"76","author":"Janssen","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"2019041115533372100_B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S2.1","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients\u20132009 update","volume":"15","author":"Cook","year":"2009","journal-title":"Endocr Pract"},{"key":"2019041115533372100_B20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0895-4356(98)00108-5","article-title":"The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment","volume":"51","author":"Ware","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2019041115533372100_B21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"2019041115533372100_B22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0895-4356(98)00097-3","article-title":"Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations","volume":"51","author":"Aaronson","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2019041115533372100_B23","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1515\/CCLM.2004.112","article-title":"Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3)","volume":"42","author":"Elmlinger","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"2019041115533372100_B24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1012552211996","article-title":"Do SF-36 summary component scores accurately summarize subscale scores?","volume":"10","author":"Taft","year":"2001","journal-title":"Qual Life Res"},{"key":"2019041115533372100_B25","first-page":"52","article-title":"Measurements of quality of life in patients with growth hormone deficiency","volume":"31","author":"Webb","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"2019041115533372100_B26","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1530\/EJE-08-0293","article-title":"Retesting the childhood-onset GH-deficient patient","volume":"159","author":"Gasco","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2019041115533372100_B27","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1210\/jc.2012-2006","article-title":"Discontinuing long-term GH replacement therapy: a randomized, placebo-controlled crossover trial in adult GH deficiency","volume":"97","author":"Filipsson Nystrom","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115533372100_B28","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1210\/jc.2005-2227","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline","volume":"91","author":"Molitch","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115533372100_B29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4158\/EP11134.OR","article-title":"Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders","volume":"18","author":"Valassi","year":"2012","journal-title":"Endocr Pract"},{"key":"2019041115533372100_B30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1477-7525-3-63","article-title":"Differential effect sizes of growth hormone replacement on quality of life, well-being and health status in growth hormone deficient patients: a meta-analysis","volume":"3","author":"Deijen","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"2019041115533372100_B31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-60761-317-6_12","article-title":"Quality of life in acromegaly and growth hormone deficiency","volume-title":"Growth Hormone Related Diseases and Therapy","author":"Webb","year":"2011"},{"key":"2019041115533372100_B32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/eje.0.1480171","article-title":"A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels","volume":"148","author":"Rietveld","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2019041115533372100_B33","first-page":"1274","article-title":"Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators","volume":"86","author":"Deal","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115533372100_B34","first-page":"82","article-title":"Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group","volume":"82","author":"Attanasio","year":"1997","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/2\/761\/13653038\/jcem0761.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T05:41:20Z","timestamp":1555047680000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/2\/761\/2833264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-2901","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,1]]}}}